Henlius Bevacizumab Trials Results Get International Recognition

As Company Submits HLX04 For Approval In China

 
• By Akriti Seth
  
China Pharma
Henlius seeks approval for its bevacizumab biosimilar in China • Source: Alamy

More from Biosimilars

More from Products